Abstract
The Gram-negative pathogen Helicobacter pylori is increasingly more resistant to the three major antibiotics (metronidazole, clarithromycin and amoxicillin) that are most commonly used to treat infection. As a result, there is an increased rate of treatment failure; this translates into an overall higher cost of treatment due to the need for increased length of treatment and/or the requirement for combination or sequential
therapy. Given the rise in antibiotic resistance, the complicated treatment regime, and issues related to patient compliance that stem from the duration and complexity of treatment, there is clearly a pressing need for the development of novel therapeutic strategies to combat H. pylori infection. As such, researchers are actively investigating the utility of antimicrobial peptides, small molecule inhibitors and naturopathic therapies. Herein we review and discuss each of these novel approaches as a means to target this important gastric pathogen.
Citations
Citations to this article as recorded by

- Pistacia vera L. as natural source against antimicrobial and antiviral resistance
Giuseppina Mandalari, Rosamaria Pennisi, Teresa Gervasi, Maria Teresa Sciortino
Frontiers in Microbiology.2024;[Epub] CrossRef - Efficacy of a standardised herbal formulation in Helicobacter pylori positive patients with gastritis or peptic ulcer: a triple-blind randomised clinical trial
Arefe Shojaeian, Alireza Khalilian, Maryam Mehrpoya, Jalal Poorolajal, Dara Dastan
Journal of Herbal Medicine.2023; 41: 100706. CrossRef - Antibacterial, Antibiofilm, and Antioxidant Activity of 15 Different Plant-Based Natural Compounds in Comparison with Ciprofloxacin and Gentamicin
Ali Pormohammad, Dave Hansen, Raymond J. Turner
Antibiotics.2022; 11(8): 1099. CrossRef - Targeting the Essential Transcription Factor HP1043 of Helicobacter pylori: A Drug Repositioning Study
Federico Antoniciello, Davide Roncarati, Annamaria Zannoni, Elena Chiti, Vincenzo Scarlato, Federica Chiappori
Frontiers in Molecular Biosciences.2022;[Epub] CrossRef -
Helicobacter pylori eradication: Exploring its impacts on the gastric mucosa
Chun-Yan Weng, Jing-Li Xu, Shao-Peng Sun, Kai-Jie Wang, Bin Lv
World Journal of Gastroenterology.2021; 27(31): 5152. CrossRef - A Comprehensive Study on the Antimicrobial Properties of Resveratrol as an Alternative Therapy
Ehsan Abedini, Ehsaneh Khodadadi, Elham Zeinalzadeh, Seyyed Reza Moaddab, Mohammad Asgharzadeh, Bahareh Mehramouz, Sounkalo Dao, Hossein Samadi Kafil, Weicheng Hu
Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1. CrossRef - Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice
Patrícia C. Henriques, Lia M. Costa, Catarina L. Seabra, Bernardo Antunes, Ricardo Silva-Carvalho, Susana Junqueira-Neto, André F. Maia, Pedro Oliveira, Ana Magalhães, Celso A. Reis, Fátima Gartner, Eliette Touati, Joana Gomes, Paulo Costa, M. Cristina L.
Acta Biomaterialia.2020; 114: 206. CrossRef - Effects of cinnamon extract on complications of treatment and eradication of Helicobacter pylori in infected people
Ghazal Imani, Alireza khalilian, Dara Dastan, Behzad Imani, Maryam Mehrpoya
Journal of Herbmed Pharmacology.2020; 9(1): 55. CrossRef - Flacourtia indica based biogenic nanoparticles: development, characterization, and bioactivity against wound associated pathogens
Farooq Ahmad, Muhammad Babar Taj, Muhammad Ramzan, Ahmad Raheel, Saima Shabbir, Muhammad Imran, Hafiz M N Iqbal
Materials Research Express.2020; 7(1): 015026. CrossRef - In vitro activity of neem (Azadirachta indica) oil extract against Helicobacter pylori
Faith C. Blum, Jatinder Singh, D. Scott Merrell
Journal of Ethnopharmacology.2019; 232: 236. CrossRef - Study of inhibitory effects of the mixture of cinnamon and ginger extracts on cagA gene expression of Helicobacter pylori by Real-Time RT-PCR technique
Morteza Azadi, Asa Ebrahimi, Azad Khaledi, Davoud Esmaeili
Gene Reports.2019; 17: 100493. CrossRef - In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains
Jun-Won Chung, Su Young Kim, Hee Jung Park, Chang Su Chung, Hee Woo Lee, Sun Mi Lee, Inki Kim, Jhang Ho Pak, Gin Hyug Lee, Jin-Yong Jeong
Gut and Liver.2017; 11(5): 648. CrossRef - Helicobacter pylori treatment: New perspectives using current experience
Amin Talebi Bezmin Abadi
Journal of Global Antimicrobial Resistance.2017; 8: 123. CrossRef -
Selective killing of
Helicobacter pylori
with pH-responsive helix–coil conformation transitionable antimicrobial polypeptides
Menghua Xiong, Yan Bao, Xin Xu, Hua Wang, Zhiyuan Han, Zhiyu Wang, Yeqing Liu, Songyin Huang, Ziyuan Song, Jinjing Chen, Richard M. Peek, Lichen Yin, Lin-Feng Chen, Jianjun Cheng
Proceedings of the National Academy of Sciences.2017; 114(48): 12675. CrossRef - Helicobacter pylori outer membrane protein, HomC, shows geographic dependent polymorphism that is influenced by the Bab family
Aeryun Kim, Stephanie L. Servetas, Jieun Kang, Jinmoon Kim, Sungil Jang, Yun Hui Choi, Hanfu Su, Yeong-Eui Jeon, Youngmin A. Hong, Yun-Jung Yoo, D. Scott Merrell, Jeong-Heon Cha
Journal of Microbiology.2016; 54(12): 846. CrossRef - Capsule Design for Blue Light Therapy against Helicobacter pylori
Zhangyong Li, Binbin Ren, Haiyan Tan, Shengrong Liu, Wei Wang, Yu Pang, Jinzhao Lin, Chen Zeng, Dipshikha Chakravortty
PLOS ONE.2016; 11(1): e0147531. CrossRef - Morphological changes in human gastric epithelial cells induced by nuclear targeting of Helicobacter pylori urease subunit A
Jung Hwa Lee, So Hyun Jun, Jung-Min Kim, Seung Chul Baik, Je Chul Lee
Journal of Microbiology.2015; 53(6): 406. CrossRef - Dietary amelioration of Helicobacter infection
Jed W. Fahey, Katherine K. Stephenson, Alison J. Wallace
Nutrition Research.2015; 35(6): 461. CrossRef - Antibiotic treatment forHelicobacter pylori: Is the end coming?
Su Young Kim
World Journal of Gastrointestinal Pharmacology and Therapeutics.2015; 6(4): 183. CrossRef - The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection
Inês C Gonçalves, Patrícia C Henriques, Catarina L Seabra, M Cristina L Martins
Expert Review of Anti-infective Therapy.2014; 12(8): 981. CrossRef